Evidence map›Paper›PMID 34703844›Full record

ArticleMolecular therapy. Methods & clinical development2021

AAV-mediated

Catherine Argyriou, Anna Polosa, Ji Yun Song, Samy Omri, Bradford Steele, Bruno Cécyre, Devin S McDougald, Erminia Di Pietro, Jean-François Bouchard, Jean Bennett and 3 more

Open access · goldAbstract read
In one paragraph

Article in Molecular therapy. Methods & clinical development, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. The peroxisome: an update on mysteries 3.0.Histochemistry and cell biology · 2024
    Review
  7. Article
  8. Article
  9. Children (Basel, Switzerland) · 2023
    Article
  10. Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Catherine ArgyriouDepartment of Human Genetics, McGill University, Montreal, QC, Canada.
Anna PolosaDepartment of Ophthalmology & Visual Sciences, McGill University, Montreal, QC, Canada.
Ji Yun SongCenter for Advanced Retinal and Ocular Therapeutics, F.M. Kirby Center for Molecular Ophthalmology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Samy OmriResearch Institute of the McGill University Health Centre, Montreal, QC, Canada.
Bradford SteeleDepartment of Biochemistry and Molecular Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Bruno CécyreSchool of Optometry, Université de Montréal, Montreal, QC, Canada.
Devin S McDougaldCenter for Advanced Retinal and Ocular Therapeutics, F.M. Kirby Center for Molecular Ophthalmology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Erminia Di PietroResearch Institute of the McGill University Health Centre, Montreal, QC, Canada.
Jean-François BouchardSchool of Optometry, Université de Montréal, Montreal, QC, Canada.
Jean BennettCenter for Advanced Retinal and Ocular Therapeutics, F.M. Kirby Center for Molecular Ophthalmology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Joseph G HaciaDepartment of Biochemistry and Molecular Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Pierre LachapelleDepartment of Ophthalmology & Visual Sciences, McGill University, Montreal, QC, Canada.
Nancy E BravermanDepartment of Human Genetics, McGill University, Montreal, QC, Canada.
McGill University Health Centre · CAUniversity of Pennsylvania · USUniversité de Montréal · CAUniversity of Southern California · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients with Zellweger spectrum disorder (ZSD) commonly present with vision loss due to mutations in

Indexed as

AAV therapyexportomermetabolic disorder gene therapyperoxisome biogenesis disorderPEX1PEX5retinal gene therapyZellweger spectrum disorder

Identifiers

PMID34703844
PMCPMC8516995
OpenAlexW3198457279

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.